LORETELLI, CRISTIAN
 Distribuzione geografica
Continente #
NA - Nord America 1.805
EU - Europa 837
AS - Asia 752
SA - Sud America 199
AF - Africa 52
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 3.648
Nazione #
US - Stati Uniti d'America 1.770
SG - Singapore 281
BR - Brasile 161
CN - Cina 132
IT - Italia 124
VN - Vietnam 124
UA - Ucraina 121
RU - Federazione Russa 114
SE - Svezia 83
DE - Germania 78
IE - Irlanda 64
TR - Turchia 60
FI - Finlandia 51
FR - Francia 49
DK - Danimarca 47
GB - Regno Unito 46
HK - Hong Kong 41
IN - India 29
KR - Corea 26
CI - Costa d'Avorio 19
NL - Olanda 19
MA - Marocco 16
MX - Messico 15
BD - Bangladesh 13
BE - Belgio 13
CA - Canada 12
AR - Argentina 8
EC - Ecuador 7
IQ - Iraq 7
JP - Giappone 7
ZA - Sudafrica 7
ES - Italia 6
ID - Indonesia 6
MY - Malesia 6
VE - Venezuela 6
CL - Cile 5
CO - Colombia 5
PL - Polonia 5
RS - Serbia 5
PK - Pakistan 4
TN - Tunisia 4
DO - Repubblica Dominicana 3
PH - Filippine 3
SA - Arabia Saudita 3
SC - Seychelles 3
UY - Uruguay 3
CR - Costa Rica 2
CZ - Repubblica Ceca 2
ET - Etiopia 2
EU - Europa 2
HN - Honduras 2
LT - Lituania 2
NP - Nepal 2
PY - Paraguay 2
AT - Austria 1
AU - Australia 1
BG - Bulgaria 1
BO - Bolivia 1
BY - Bielorussia 1
GR - Grecia 1
HU - Ungheria 1
IL - Israele 1
IM - Isola di Man 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
MT - Malta 1
NO - Norvegia 1
OM - Oman 1
PE - Perù 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
UZ - Uzbekistan 1
Totale 3.648
Città #
Ashburn 279
Singapore 195
Chandler 193
Jacksonville 128
Fairfield 108
San Jose 65
Boardman 63
Dublin 63
Wilmington 63
Ann Arbor 62
Dallas 58
New York 57
Woodbridge 55
Houston 44
Ho Chi Minh City 42
Beijing 41
Centro 41
Hong Kong 40
Seattle 38
Cambridge 36
Los Angeles 30
Hanoi 27
Lawrence 26
Princeton 26
San Mateo 26
The Dalles 26
Lauterbourg 23
Moscow 23
Des Moines 22
Abidjan 19
Munich 18
Orem 17
Turin 16
Chennai 15
Turku 15
São Paulo 13
Atlanta 12
Hefei 11
Helsinki 11
San Diego 11
Chicago 10
Brussels 9
Amsterdam 8
Mexico City 8
Ancona 7
Brasília 6
Buffalo 6
Cagliari 6
Denver 6
Johannesburg 6
London 6
Tokyo 6
Brooklyn 5
Frankfurt am Main 5
Montreal 5
San Francisco 5
Santa Clara 5
Stockholm 5
Belgrade 4
Como 4
Curitiba 4
Da Nang 4
Haiphong 4
Izmir 4
Kilburn 4
New Delhi 4
Paris 4
Poplar 4
Quito 4
Rio de Janeiro 4
Salt Lake City 4
Waanrode 4
Warsaw 4
Washington 4
Wuxi 4
Belo Horizonte 3
Boston 3
Bến Tre 3
City of London 3
Erbil 3
Fortaleza 3
Guangzhou 3
Norwalk 3
Phoenix 3
Santiago 3
Wuhan 3
Addis Ababa 2
Ankara 2
Aparecida de Goiânia 2
Arzano 2
Baghdad 2
Bogotá 2
Campinas 2
Caracas 2
Cardiff 2
Columbus 2
Guayaquil 2
Hyderabad 2
Hải Dương 2
Indaiatuba 2
Totale 2.301
Nome #
An intronic mutation in MLH1 associated with familial colon and breast cancer. 194
Angiogenesis genotyping and clinical outcome during regorafenib treatment in metastatic colorectal cancer patients 190
Pre-treatment lactate dehydrogenase levels as predictor of efficacy of first-line bevacizumab-based therapy in metastatic colorectal cancer patients. 174
KRAS: To be or not to be targeted? Biologic and computational analyses in pancreatic adenocarcinoma 164
Angiogenesis Genotyping and Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib: The ALICE-2 Study 164
Tumor angiogenesis genotyping and efficacy of first-line chemotherapy in metastatic gastric cancer patients. 152
Phosphorylated AKT and MAPK expression in primary tumours and in corresponding metastases and clinical outcome in colorectal cancer patients receiving irinotecan-cetuximab. 152
A missense germline mutation in exon 7 of the MSH2 gene in a HNPCC family from center-Italy. 149
VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: the ALICE-1 study 149
'Secrets and lies'--the difficulties of communicating within families with inherited cancer syndromes. 145
CANCER STEM CELL GENETIC PROFILE AS PREDICTOR OF RELAPSE IN RADICALLY RESECTED COLORECTAL CANCER 143
Sub-cellular localization analysis of MSH6 missense mutations does not reveal an overt MSH6 nuclear transport impairment. 142
VEGF and VEGFR polymorphisms affect clinical outcome in advanced renal cell carcinoma patients receiving first-line sunitinib 138
Assessing the pathogenicity of MLH1 missense mutations in patients with suspected hereditary nonpolyposis colorectal cancer: correlation with clinical, genetic and functional features. 136
The role of LDH serum levels in predicting global outcome in HCC patients undergoing TACE: implications for clinical management. 134
Role of vascular endothelial growth factor (VEGF) and VEGF-R genotyping in guiding the metastatic process in pT4a resected gastric cancer patients. 134
Phase II study of pharmacogenetic-tailored therapy in elderly colorectal cancer patients. 128
Mutations of hMLH1 and hMSH2 in patients with suspected hereditary nonpolyposis colorectal cancer: correlation with microsatellite instability and abnormalities of mismatch repair protein expression. 127
Angiogenesis genotyping in the selection of first-line treatment with either sunitinib or pazopanib for advanced renal cell carcinoma 127
MSH2 splice site mutation and endometrial cancer. 126
Role of β4 integrin in HER-3-negative, K-RAS wild-type metastatic colorectal tumors receiving cetuximab. 124
MSH2 missense mutations and HNPCC syndrome: pathogenicity assessment in a human expression system 123
The role of tumor vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) polymorphisms in the prediction of clinical outcome for advanced renal cell carcinoma patients receiving first-line sunitinib 123
The role of LDH serum levels in predicting global outcome in HCC patients treated with sorafenib: implications for clinical management 122
Effectiveness of the CRCAPRO program in identifying patients suspected for HNPCC. 119
Alterazione epigenetica di BRCA1 nei carcinomi mammari 115
Totale 3.694
Categoria #
all - tutte 15.808
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.808


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021123 0 0 0 0 0 0 0 0 0 55 43 25
2021/2022215 6 60 2 3 4 11 11 12 13 34 16 43
2022/2023499 30 70 28 42 53 67 0 29 120 4 43 13
2023/2024234 34 4 25 25 39 52 6 8 0 3 5 33
2024/2025476 62 47 12 6 37 8 56 13 96 28 56 55
2025/20261.328 112 112 62 199 229 110 203 113 91 97 0 0
Totale 3.694